Latest Stock Market News

As of 30-Sep-2021, promoters held 74.99 per cent stake in the company, while FIIs held 9.95 per cent and domestic institutional investors had 6.21 per cent.

The Nifty Pharma index was trading 0.6 per cent down at 13890.7.

Analysts across the spectrum have said the counter was a good buy opportunity. Most of them also raised their respective target prices in the hopes that the company would strengthen its dominant status.

“Real estate as a space looks far more convincing than ever before as far as growth is concerned and most importantly, land prices are not surging as much and the construction cost is still factored in. I remain positive in this particular space.”

PNC Infratech Ltd. key Products/Revenue Segments include Contract Revenue, Material and Scrap for the year ending 31-Mar-2021.

The majority of the brokerages are positive over the issue of the Kolkata-based company and have suggested investors bid for the IPO for listing pop and long-term gains.

The stock quoted a 52-week high price of Rs 604.0 and low of Rs 429.8.

"The company board will meet shortly to enable workout for further fund raising plan after the rights issue of Rs 400 crore. There are options for ECBs and Rupee loans from banking channels to reduce the cost of debt. Fully, hedged ECBs will cost around 11 per cent far less than existing rates. However, it may be in combination of Rupee and foreign currency loan," sources aware of the development told PTI.

Porinju Veliyath holds at least 19 stocks in his portfolio with an investment of over Rs 210 crore, according to Trendlyne.

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 6069.19 Crore) operating in Hospitals & Allied Services sector.